Copy
View this email in your browser
               
This Issue
Highlights from ObesityWeek 2019: Pediatric Obesity
STOP Resources
NOVEMBER
2019


Greetings,

ObesityWeek, the largest obesity conference in the world, took place this month. What were the takeaways? Most prominently, it is time for us to tackle childhood obesity, specifically severe childhood obesity.

We know that the rates of childhood and adolescent obesity have risen steadily over the past few decades, putting younger people at risk of obesity-related diseases typically seen in adults, such as type 2 diabetes. In response to these concerns, several sessions at ObesityWeek focused on the need for better treatments for children and adolescents, while addressing concerns that many have about putting children through the physical and psychological stress of obesity treatment.

A new clinical update on the treatment of adolescent obesity, published in JAMA, recommends that adolescents have access to many of the same options as adults, ranging from behavioral interventions to surgery and including pharmacotherapy, depending on the patient’s BMI, preferences, and medical history.



In addition, new evidence supporting the safety and effectiveness of bariatric surgery in adolescents with severe obesity prompted the AAP to provide recommendations for bariatric surgery. The new recommendations urge pediatricians to assess their patients for severe obesity and refer them to surgical programs when appropriate. These new recommendations also address the barriers that stand in the way of those seeking bariatric surgery. One study found that over half of adolescents seeking surgical treatment for obesity were initially denied by insurance providers, most commonly because they were under the age of eighteen.

Unfortunately, the issue of reluctant insurers is not limited to bariatric surgery, and many evidence-based treatments are inaccessible to pediatric patients for financial reasons. Regarding pharmacotherapy, a lack of clinical trials is the most significant barrier that patients and physicians face. Only phentermine and orlistat have FDA approval for obesity treatment in adolescents.

Parents and the public have expressed worries that behavioral interventions, pharmacotherapy, and surgery could put children at risk of complications, including the development of eating disorders. However, research has shown that professionally administered weight loss programs pose minimal risk to children and adolescents. In fact, one study found that professional obesity treatment was actually correlated with a decrease in eating disorder symptoms. Parents considering talking to their child about their weight can consult our guide, Weigh In: Talking to Your Children About Weight and Health for suggestions.

It’s important to remember that for many children and adolescents with severe obesity, the benefits of treatment far outweigh the possible risks. It is imperative that children and adolescents have access to well-researched, evidence-based treatments for severe obesity. Researching the safety and efficacy of anti-obesity drugs for adolescents and advocating for insurance coverage for pharmacotherapy and surgery needs to be a priority. The focus that this year’s ObesityWeek sessions put on these ever-growing needs should serve as a call to action for the coming year, compelling researchers, advocates, and policymakers to redouble our efforts to facilitate the treatment of severe childhood obesity.
 

Thanks, 
       

Share Share
Tweet Tweet
Forward Forward
Upcoming Events

Mar 1-7: Obesity Care Week 2020




 
Announcements

November is National Diabetes Month
Italy Recognizes Obesity as Chronic Disease
ACSM National Youth Sports Strategy Briefing
 
Obesity Care Week 2020: March 1-7
Originally founded as National Obesity Care Week (NOCW), this awareness campaign has come a long way since its inception in 2015. For instance, in 2019, NOCW became Obesity Care Week (OCW) to emphasize a more global vision for a society that understands, respects and accepts the complexities of obesity and values science and clinically-based care.
 
With the mission to move forward and make a global impact, OCW has also moved to a different date and it's right around the corner! OCW2020 will take place from March 1st-7th,2020 and will have different focus days in which can help us by raising awareness and taking action:
  • March 1st: Launch Day
  • March 2nd: Weight Bias Day
  • March 3rd: Obesity Treatment Day
  • March 4th: World Obesity Day
  • March 5th: Access to Care Day
  • March 6th: Childhood Obesity Day
  • March 7th: "I Care" Day
OCW has evolved since its inception, in addition to its name change and new dates, it will now also align with World Obesity Day and dedicate a focus day to Childhood Obesity. We are excited about these new changes and can’t wait to work with all our Champions and pledge takers to advocate for a better world for people living with obesity.
 
We hope to count on your support during OCW2020, make sure to save the date! For more information on how you can get involved, visit obesitycareweek.org.
The Obesity (Under) Treatment Conundrum
In a commentary published in Obesity this month, STOP Director Dr. William Dietz discusses the challenges faced by patients and providers in the treatment of obesity. Prompted by the finding that less than 2% of eligible patients receive a prescription for obesity pharmacotherapy, Dr. Dietz explores the reasons why effective, evidence-based obesity treatments remain underutilized.

Read the full article here.
 
Obesity Now Recognized as a Chronic Disease in Italy
On November 13, obesity advocates in Italy succeeded in getting official parliamentary recognition of obesity as a chronic disease. The European Association for the Study of Obesity (EASO) reports:

"This collaborative, multi-stakeholder effort was long in the making and includes a Charter of Human Rights for People Living with Obesity. The document enumerates actions necessary for the protection of health for obesity prevention and treatment of people living with obesity."

Learn more here
CDC Reports on the Prevalence of Obesity among WIC Participants by State
The CDC shared promising findings from their Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) earlier this year, reporting that there was a significant decrease in obesity prevalence among participants aged 2 to 4 years old. On November 22, they released a state-specific analysis, reporting:

"During 2010–2016, statistically significant decreases in obesity prevalence among WIC beneficiaries aged 2–4 years occurred in 41 of 56 WIC state or territory agencies; obesity prevalence ranged from 7.8% to 19.8%."

Learn more here.
 
The 2019 Report on the Lancet Countdown on Health and Climate Change
The Lancet Countdown is an international, multidisciplinary collaboration, dedicated to monitoring the evolving health profile of climate change, and providing an independent assessment of the delivery of commitments made by governments worldwide under the Paris Agreement.

The 2019 report concludes that although many countries are scaling up efforts to combat climate change and the effects it will have on health, there is still much more to be done to achieve the goal of ensuring that the health of a child born today is not defined by a changing climate.

Read the full report here.

Scaling‐up evidence‐based obesity interventions: A systematic review assessing intervention adaptations and effectiveness and quantifying the scale‐up penalty


McCrabb and colleagues reviewed 10 studies that were scaled up from their original randomized control trial setups. These scaled up interventions reached a larger population, but sometimes at the expense of efficacy. They calculated that, "across measures of weight status, physical activity/sedentary behaviour, and nutrition, the effects reported in scaled‐up interventions were typically 75% or less of the effects reported in pre–scale‐up efficacy trials," and concluded that, "the findings underscore the challenge of scaling‐up obesity interventions."

Learn more about their results here.
November is National Diabetes Month
The theme of National Diabetes Month 2019 was Take Diabetes to Heart: Linking Diabetes and Cardiovascular Disease. To find out more about the link between diabetes and cardiovascular disease, check out the National Diabetes Month 2019 Toolkit. This resource, produced by NIH's National Institute of Diabetes and Digestive and Kidney Diseases, has fact sheets, infographics, and resources for both patients and providers.
American College of Sports Medicine: National Youth Sports Strategy
A strategy for removing barriers to youth sports participation was the focus of a recent congressional briefing, hosted by the American College of Sports Medicine (ACSM), the Congressional Caucus on Youth Sports and other strategic partners. Subject matter experts and congressional representatives presented the National Youth Sports Strategy to a full room of stakeholders at the Capitol Visitors Center.

Co-chairs of the Congressional Caucus on Youth Sports, Representative Ron Kind, Rodney Davis and Marc Veasey supported the briefing which discussed the strategy and its four pillars: increase awareness of the benefits of participation in sports; promote private and public sector strategies to increase participation in sports; develop metrics that gauge youth sports participation; and establish a national and local strategy to recruit volunteers who will encourage and support youth participation in sports.

As the prevalence of sedentary lifestyles and childhood obesity rises, parents and children can find it difficult to participate in youth sports due to cost, lack of time and a shortage of inclusive options.The National Youth Sports Strategy was designed to address these challenges head-on with its vision of a day when all youth will have the opportunity, motivation, and access to play sports – regardless of their race, ethnicity, sex, ability or ZIP code.
 



Redstone Center Update: Redstone Center Staff Urge DC Council Committee to Improve Nutrition Training for District Providers

STOP Director Dr. William Dietz is Chair of the Sumner M. Redstone Global Center for Prevention and Wellness – home to the STOP Obesity Alliance – at George Washington University’s Milken Institute School of Public Health. Highlights from this month’s Center activities include the following:
 

On November 13, 2019, Jeff Hild, Policy Director at the Redstone Center, and Nichole Jannah, Research Associate at the Strategies to Overcome and Prevent (STOP) Obesity Alliance, provided testimony to the Council’s Committee on Health supporting passage of the Continuing Nutrition Education Amendment Act. Passage of the Act would develop and offer DC-specific continuing education courses that connect providers with the information and tools they need to engage effectively with the District’s ongoing nutrition initiatives and resources.  "To our knowledge, the proposed bill represents the first comprehensive legislative effort to ensure that health professionals are equipped with the knowledge and skills needed to optimize the nutritional status of District residents. If implemented as written, we expect that the legislation will be associated with increased rates of nutrition counseling and concomitant increases in other forms of evidence-based obesity care in routine clinical practice...and may contribute to measurable improvements in nutrition-related population health outcomes," Hild and Jannah shared. Read full testimony here.

 
 
Copyright © 2019 STOP Obesity Alliance, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.